Delegation of the European Union to Japan

European Commission authorises second safe and effective vaccine against COVID-19

Brussels, 06/01/2021 - 00:00, UNIQUE ID: 210107_1
Press releases

EU News 2/2021

Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.

Editorial Sections: